META-BETA

RecruitingPhase NA

Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.

Experimental, Drug-free, Cross-sectional, Single-centre Study to Assess the Association Between Metabotypes of Dietary (Poly)Phenols and Beta-cell Mass and Function.

Lead sponsor

Azienda Ospedaliero-Universitaria di Parma

Asset

Exenatide

GLP-1 agonist

Listed sites

Recruiting sites

Enrollment

estimated

Study population

Healthy volunteers

Key I/E criterion

—

Primary endpoint

•Specific metabotypes (MTs) that associate

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT06888167

Org study ID683-2023

Timeline

Milestones

Study start2024-10-14actual

Study first posted2025-03-21actual

Last update posted2025-03-21actual

Primary completion2025-12-31estimated

Study completion2026-02-28estimated

Assets

Investigational agents

Exenatide

Study populations

Who this study enrolls

Healthy volunteers

Eligibility

Who can enroll

Minimum age18 Years

SexAll

Healthy volunteersAccepted

Inclusion criteria

•Having been enrolled in the OPCT study;

•Ability to understand the methods, purposes and implications of the study, and to give free and informed consent.

Exclusion criteria

•Pregnancy or breastfeeding;

•Previous exposure to ionizing radiation in research programs;

•History of psychiatric illness or alcohol abuse;

•Head trauma;

•Active neurological disease;

•Claustrophobia;

•Active malignant neoplastic disease.

Endpoints (5)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)

Glycemic / diabetes

1 endpoint

Secondary/protocol endpoint/low confidence

Pancreatic beta cell function (BCF)